trial · primary record
BI 765179
Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 151 |
| Primary completion | 2028-02-17 |
| Primary endpoint | Phase 1a: Maximum Tolerated Dose (MTD) |
| Registry ID | NCT04958239 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:35.119Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04958239
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.